BBA
GBT
Baker Bros. Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,732,502
| Closed | -$254M | – | 128 |
|
|
2022
Q3 | $254M | Hold |
3,732,502
| – | – | 1.66% | 7 |
|
|
2022
Q2 | $119M | Buy |
3,732,502
+417,737
| +13% | +$13.3M | 0.68% | 10 |
|
|
2022
Q1 | $115M | Hold |
3,314,765
| – | – | 0.66% | 12 |
|
|
2021
Q4 | $97M | Buy |
3,314,765
+97,324
| +3% | +$2.85M | 0.47% | 18 |
|
|
2021
Q3 | $82M | Hold |
3,217,441
| – | – | 0.36% | 23 |
|
|
2021
Q2 | $113M | Hold |
3,217,441
| – | – | 0.49% | 19 |
|
|
2021
Q1 | $131M | Buy |
3,217,441
+2,297,066
| +250% | +$93.6M | 0.57% | 17 |
|
|
2020
Q4 | $39.9M | Hold |
920,375
| – | – | 0.15% | 41 |
|
|
2020
Q3 | $50.7M | Buy |
920,375
+873,375
| +1,858% | +$48.2M | 0.2% | 31 |
|
|
2020
Q2 | $2.97M | Hold |
47,000
| – | – | 0.01% | 91 |
|
|
2020
Q1 | $2.4M | Buy |
+47,000
| New | +$2.4M | 0.01% | 86 |
|
|
2016
Q2 | – | Sell |
-600,000
| Closed | -$9.52M | – | 141 |
|
|
2016
Q1 | $9.52M | Buy |
600,000
+200,000
| +50% | +$3.17M | 0.1% | 57 |
|
|
2015
Q4 | $12.9M | Buy |
400,000
+200,000
| +100% | +$6.47M | 0.11% | 58 |
|
|
2015
Q3 | $8.43M | Buy |
+200,000
| New | +$8.43M | 0.08% | 66 |
|